Methods for modulating brain damage
   
   

Methods are disclosed for modulating brain damage mediated by non-NMDA ionotropic glutamate receptor antagonists, as topiramate, in conditions such as periventricular leukomalacia, cerebral palsy, mental retardation and neonatal stroke.

 
Web www.patentalert.com

< Use of diterpene compound as a therapeutic agent of inflammation, immune disease or cancer

< Ordered liquid crystalline cleansing composition with benefit agent particles

> Metal hydride composite materials

> Urea and nitrogen based compounds as feeding stimulants/aggregants and masking agents of unpalatable chemicals for subterranean termites
~ 00196